Are hematopoietic cell transplant recipients with Gram-negative bacteremia spending more time outpatient while on intravenous antibiotics? Addressing trends over 10 years at a single center.

2 , 3 , 4 The evidence of such associations, coupled with the availability of once‐daily broad‐spectrum antibiotics, such as ertapenem, and an overall trend toward outpatient HCT care supports the idea that HCT recipients are increasingly being treated for GNRBs in ambulatory care settings. 2 , 3 , 4 To examine if HCT recipients with GNRBs are, in fact, receiving more care in outpatient settings, we evaluated if the proportion of targeted antibiotic treatment time allogeneic HCT recipients with GNRBs in ambulatory settings changed over a 10‐year period among all patients and among patients with similar pretransplant complexities, GNRB complexity, and posttransplant complications.

also in 4,871 other papers